Open AccessNCCN CML Guidelines Now Include Second- and Third-Generation TKIs
Author(s) -
Ed Susman
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000397189.69445.7a
Subject(s) - nilotinib , dasatinib , medicine , imatinib , chronic myelogenous leukemia , cancer , gist , tyrosine kinase , tyrosine kinase inhibitor , first line , oncology , family medicine , leukemia , myeloid leukemia , stromal cell , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom